Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELENIB: Selenium and Vitamin E in Bladder Cancer
NCT00553345Phase 3Unknown
- Sponsor
- University of Birmingham
- Start
- Dec 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of selenium, vitamin e in bladder cancer, sponsored by University of Birmingham. Status: unknown.
02
Drugs
seleniumvitamin e
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00553345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553345.